Scordo Maria Gabriella, Caputi Achille P, D'Arrigo Concetta, Fava Giuseppina, Spina Edoardo
Department of Experimental and Clinical Medicine and Pharmacology, Section of Pharmacology, University of Messina, Torre Biologica, Policlinico Universitario, Via Consolare Valeria-Gazzi, 98125 Messina, Italy.
Pharmacol Res. 2004 Aug;50(2):195-200. doi: 10.1016/j.phrs.2004.01.004.
The polymorphic cytochrome P450 isoenzymes (CYPs) 2C9, 2C19 and 2D6 metabolise many important drugs, as well as other xenobiotics. Their polymorphism gives rise to important interindividual and interethnic variability in the metabolism and disposition of several therapeutic agents and may cause differences in the clinical response to these drugs. In this study, we determined the genotype profile of a random Italian population in order to compare the CYP2C9, CYP2C19 and CYP2D6 allele frequencies among Italians with previous findings in other Caucasian populations. Frequencies for the major CYP2C9, CYP2C19 and CYP2D6 mutated alleles and genotypes have been evaluated in 360 unrelated healthy Italian volunteers (210 males and 150 females, aged 19-52 years). Genotyping has been carried out on peripheral leukocytes DNA by molecular biology techniques (PCR, RFLP, long-PCR). CYP2C9, CYP2C19 and CYP2D6 allele and genotype frequencies resulted in equilibrium with the Hardy-Weinberg equation. One hundred and fourteen subjects (31.7%) carried one and 23 subjects (6.4%) carried two CYP2C9 mutated alleles. Sixty-eight (18.9%) volunteers were found to be heterozygous and six (1.7%) homozygous for the CYP2C192, while no CYP2C193 was detected in the evaluated population. Volunteers could be divided into four CYP2D6 genotypes groups: 192 subjects (53.3%) with no mutated alleles (homozygous extensive metabolisers, EM), 126 (35.0%) with one mutated allele (heterozygous EM), 12 (3.4%) with two mutated alleles (poor metabolisers, PM) and 30 (8.3%) with extracopies of a functional gene (ultrarapid metabolisers, UM). Frequencies of both CYP2C9 and CYP2C19 allelic variants, as well as CYP2D6 detrimental alleles, in Italian subjects were similar to those of other Caucasian populations. Conversely, the prevalence of CYP2D6 gene duplication among Italians resulted very high, confirming the higher frequency of CYP2D6 UM in the Mediterranean area compared to Northern Europe.
多态性细胞色素P450同工酶(CYPs)2C9、2C19和2D6可代谢许多重要药物以及其他外源性物质。它们的多态性导致多种治疗药物在代谢和处置方面存在重要的个体间和种族间差异,并可能引起对这些药物临床反应的不同。在本研究中,我们测定了意大利随机人群的基因型谱,以便比较意大利人CYP2C9、CYP2C19和CYP2D6等位基因频率与之前在其他白种人群中的研究结果。在360名无亲缘关系的健康意大利志愿者(210名男性和150名女性,年龄19 - 52岁)中评估了主要CYP2C9、CYP2C19和CYP2D6突变等位基因及基因型的频率。通过分子生物学技术(PCR、RFLP、长PCR)对外周血白细胞DNA进行基因分型。CYP2C9、CYP2C19和CYP2D6等位基因及基因型频率符合哈迪 - 温伯格平衡。114名受试者(31.7%)携带一个,23名受试者(6.4%)携带两个CYP2C9突变等位基因。68名(18.9%)志愿者被发现为CYP2C192杂合子,6名(1.7%)为纯合子,而在评估人群中未检测到CYP2C193。志愿者可分为四个CYP2D6基因型组:192名受试者(53.3%)无突变等位基因(纯合广泛代谢者,EM),126名(35.0%)有一个突变等位基因(杂合EM),12名(3.4%)有两个突变等位基因(慢代谢者,PM),30名(8.3%)有一个功能基因的额外拷贝(超快代谢者,UM)。意大利受试者中CYP2C9和CYP2C19等位基因变体以及CYP2D6有害等位基因的频率与其他白种人群相似。相反,意大利人CYP2D6基因重复的发生率非常高,证实了与北欧相比,地中海地区CYP2D6超快代谢者的频率更高。